Advertisement

Risk of gallstones in patients with obstructive sleep apnea: a nationwide observational cohort study

  • Chien-Hua Chen
  • Cheng-Li Lin
  • Chung-Y. Hsu
  • Chia-Hung Kao
Epidemiology • Original Article
  • 75 Downloads

Abstract

Purpose

To assess the association between obstructive sleep apnea (OSA) and gallstones.

Methods

We identified 3827 patients aged ≥ 20 years with OSA between 2000 and 2010 from the Longitudinal Health Insurance Research Database 2000 (LHID2000) as the study cohort. The beneficiaries without OSA were randomly selected and propensity-matched with the study cohort in a 1:1 ratio according to age; sex; occupation; urbanization; comorbidities of hypothyroidism, hyperlipidemia, diabetes, liver cirrhosis, alcohol-related illness, hypertension, chronic obstructive pulmonary disease (COPD), obesity, inflammatory bowel disease, stroke, coronary artery disease (CAD), hepatitis B virus, and hepatitis C virus; and the index year. All patients were followed until the end of 2011 or withdrawal from the National Health Insurance program to determine the incidence of gallstones.

Results

The prevalence of OSA was higher in men (67.3%) and in patients younger than 49 years (57.0%; mean age 47.8 ± 15.1 years). The cumulative incidence of gallstones was higher in the OSA cohort than in the non-OSA cohort (log-rank test, P < 0.001). Compared with patients without OSA, those with OSA had an increased risk of gallstones (adjusted hazard ratio = 1.53, 95% confidence interval = 1.16–2.03) after adjustment for age, sex, hyperlipidemia, diabetes, hypertension, COPD, stroke, and CAD.

Conclusion

The study shows a strong association between OSA and gallstones. Moreover, our findings suggest the requirement for survey and health education for gallstones in OSA and further studies to verify whether the treatment of OSA can reduce the risk of gallstones.

Keywords

Obstructive sleep apnea Gallstones Comorbidities 

Abbreviations

OSA

obstructive sleep apnea

LHID2000

Longitudinal Health Insurance Research Database 2000

COPD

chronic obstructive pulmonary disease

BMI

body mass index

IBD

inflammatory bowel disease

CAD

coronary artery disease

HBV

hepatitis B virus

HCV

hepatitis C virus infection

CI

confidence interval

aHR

adjusted hazard ratio

NHI

National Health Insurance

ICD-9-CM

International Classification of Diseases, Ninth Edition, Clinical Modification

AHI

apnea–hypopnea index

NAFLD

non-alcoholic fatty liver disease

Notes

Author contributions

Conceptualization: CHC, CHK

Methodology: CHC, CLL, CHK

Software: CLL, CHK

Validation: CHC, CLL, CHK

Formal analysis: CHC, CLL, CHK

Investigation: CHC, CHK

Resources: CHC, CHK

Data curation: CHC, CLL, CHK

Writing (original draft preparation): all authors

Writing (review and editing): all authors

Visualization: all authors

Supervision: CHC, CHK

Project administration: CYH, CHK

Funding acquisition: CYH, CHK

Funding information

This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDUB-212-123004), China Medical University Hospital (DMR-107-192), Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The NHIRD encrypts patient personal information to protect privacy and provides researchers with anonymous identification numbers associated with relevant claim information, including sex, date of birth, medical services received, and prescriptions. Therefore, patient consent is not required to access the NHIRD. This study was approved to fulfill the condition for exemption by the Institutional Review Board (IRB) of China Medical University (CMUH104-REC2-115-CR2). The IRB also specifically waived the consent requirement.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Shaffer EA (2006) Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20:981–996CrossRefPubMedGoogle Scholar
  2. 2.
    Chen CY, Lu CL, Huang YS, Tam TN, Chao Y, Chang FY, Lee SD (1998) Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing 27:437–441CrossRefPubMedGoogle Scholar
  3. 3.
    Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, Yeh YH, Wu HS, Der-Aur Chou*, Yueh SK Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol 2006;21:1737–43Google Scholar
  4. 4.
    Ross M, Brown M, McLaughlin K, Atkinson P, Thompson J, Powelson S, Clark S, Lang E (2011) Emergency physician-performed ultrasound to diagnose cholelithiasis: a systematic review. Acad Emerg Med 18:227–235CrossRefPubMedGoogle Scholar
  5. 5.
    Yadav D, Lowenfels AB (2006) Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas 33:323–330CrossRefPubMedGoogle Scholar
  6. 6.
    Salek J, Livote E, Sideridis K, Bank S (2009) Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis. J Clin Gastroenterol 43:171–175CrossRefPubMedGoogle Scholar
  7. 7.
    Gurusamy KS, Davidson BR (2014) Gallstones. BMJ 348:g2669CrossRefPubMedGoogle Scholar
  8. 8.
    Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D (1983) Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med 99:199–204CrossRefPubMedGoogle Scholar
  9. 9.
    Punjabi NM (2008) The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5:136–143CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gozal D, Farre R, Nieto FJ (2016) Obstructive sleep apnea and cancer: epidemiologic links and theoretical biological constructs. Sleep Med Rev 27:43–55CrossRefPubMedGoogle Scholar
  11. 11.
    Marshall NS, Wong KKH, Cullen SRJ, Knuiman MW, Grunstein RR (2014) Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study Cohort. J Clin Sleep Med 10:355–362PubMedPubMedCentralGoogle Scholar
  12. 12.
    Unnikrishnan D, Jun J, Polotsky V (2015) Inflammation in sleep apnea: an update. Rev Endocr Metab Disord 16:25–34CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Database NHIR. Taiwan, http://nhird.nhri.org.tw/en/index.html (cited in 2015)
  14. 14.
    Chen CH, Lin CL, Kao CH (2016) Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis. Osteoporos Int 27:2117–2126CrossRefPubMedGoogle Scholar
  15. 15.
    Chen CH, Lin CL, Kao CH (2016) Association between gallbladder stone disease and prostate cancer: a nationwide population-based study. Oncotarget 7:64380PubMedPubMedCentralGoogle Scholar
  16. 16.
    Qaseem A, Dallas P, Owens DK, Starkey M, Holty Jon-Erik C, Shekelle P (2014) Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 161:210–220CrossRefPubMedGoogle Scholar
  17. 17.
    O'Connor GT, Lind BK, Lee ET, Nieto FJ, Redline S, Samet JM et al (2003) Predictors of sleep-apnea-disordered breathing with race and ethnicity: the Sleep Heart Health Study. Sleep 26(74):79Google Scholar
  18. 18.
    Duran J, Esnaola S, Rubio R, Iztueta A (2001) Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 tp 70 yr. Am J Respir Crit Care Med 163:685–689CrossRefPubMedGoogle Scholar
  19. 19.
    Launois SH, Pepin JL, Levy P (2007) Sleep apnea in the elderly: a specific entity? Sleep Med Rev 11:87–97CrossRefPubMedGoogle Scholar
  20. 20.
    Punjabi NM, Newman AB, Young TB, Resnick HE, Sanders MH (2008) Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas. Am J Respir Crit Care Med 177:1150–1155CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T, American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, American Heart Association Stroke Council, American Heart Association Council on Cardiovascular Nursing, American College of Cardiology Foundation (2008) Sleep apnea and cardiovascular disease. Circulation 118:1080–1111CrossRefPubMedGoogle Scholar
  22. 22.
    Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE (2004) Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521–530CrossRefPubMedGoogle Scholar
  23. 23.
    López-Acevedo MN, Torres-Palacios A, Ocasio-Tascón ME, Campos-Santiago Z, Rodríguez-Cintrón W (2009) Overlap syndrome: an indication for sleep studies? Sleep Breath 13:409–413CrossRefPubMedGoogle Scholar
  24. 24.
    Drager LF, Jun J, Polotsky VY (2010) Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 17:161–165CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Smelt AH (2010) Triglycerides and gallstone formation. Clin Chim Acta 411:1625–1631CrossRefPubMedGoogle Scholar
  26. 26.
    Liew PL, Wang W, Lee YC, Huang MT, Lin YC, Lee WJ (2007) Gallbladder disease among obese patients in Taiwan. Obes Surg 17:383–390CrossRefPubMedGoogle Scholar
  27. 27.
    Somer VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904CrossRefGoogle Scholar
  28. 28.
    Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ (2015) Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat. J Clin Sleep Med 11:475–485PubMedPubMedCentralGoogle Scholar
  29. 29.
    Ness GC, Zhao Z, Wiggins L (1994) Insulin and glucagon modulate hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by affecting immunoreactive protein levels. J Biol Chem 269:29168–29172PubMedGoogle Scholar
  30. 30.
    Chait A, Bierman EL, Albers JJ (1979) Low-density lipoprotein receptor activity in cultured human skin fibroblasts: mechanism of insulin-induced stimulation. J Clin Invest 64:1309–1319CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Petitti DB, Friedman GD, Klatsky AL (1981) Association of a history of gallbladder disease with a reduced concentration of high-density- lipoprotein cholesterol. N Engl J Med 304:1396–1398CrossRefPubMedGoogle Scholar
  32. 32.
    Ko CW, Beresford SAA, Schulte SJ, Lee SP (2008) Insulin resistance and incident gallbladder disease in pregnancy. Clin Gastroenterol Hepatol 6:76–81CrossRefPubMedGoogle Scholar
  33. 33.
    Maurer KJ, Carey MC, Fox JG (2009) Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 136:425–440CrossRefPubMedGoogle Scholar
  34. 34.
    Camilleri M, Malhi H, Acosta A (2017) Gastrointestinal complications of obesity. Gastroenterology 152:1656–1670CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK (2010) Interactions between obesity and obstructive sleep apnea. Chest 137:711–719CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Chien-Hua Chen
    • 1
    • 2
    • 3
    • 4
  • Cheng-Li Lin
    • 5
    • 6
  • Chung-Y. Hsu
    • 7
  • Chia-Hung Kao
    • 7
    • 8
    • 9
  1. 1.Digestive Disease CenterShow-Chwan Memorial HospitalChanghuaTaiwan
  2. 2.Digestive Disease CenterChangbing Show-Chwan Memorial HospitalLukangTaiwan
  3. 3.Department of Food Science and TechnologyHungkuang UniversityTaichungTaiwan
  4. 4.Chung Chou University of Science and TechnologyYuanlinTaiwan
  5. 5.Management Office for Health DataChina Medical University HospitalTaichungTaiwan
  6. 6.College of MedicineChina Medical UniversityTaichungTaiwan
  7. 7.Graduate Institute of Biomedical Sciences, School of Medicine, College of MedicineChina Medical UniversityTaichungTaiwan
  8. 8.Department of Nuclear Medicine and PET CenterChina Medical University HospitalTaichungTaiwan
  9. 9.Department of Bioinformatics and Medical EngineeringAsia UniversityTaichungTaiwan

Personalised recommendations